Article
[TP53 mutations and molecular epidemiology].
Gan to kagaku ryoho. Cancer & chemotherapy - 1 May 2007
Otsuka Kazunori, Ishioka Chikashi
Abstract excerpt
Tumor suppressor p53 protein is activated by a variety of cellular stresses through several pathways and transactivates its downstream genes, including regulators of cell cycle, apoptosis and DNA repair. The loss of p53 function by TP53 gene mutations therefore fails to activate these genes and is thought to be a critical cause of carcinogenesis and/or tumor progression. TP53 is one of the most frequently mutated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
